• CHIR-99021: A Time-Resolved Axonogenesis Tool

  2026-09-15

  CHIR-99021 (CT99021) is more than a pluripotency reagent: it can serve as a time-controlled GSK-3 perturbation in neuronal differentiation assays. This article connects Wnt/β-catenin signaling with isoform-aware TRIM46 analysis and practical assay design.

• S-Adenosylhomocysteine in Neural Assays

  2026-09-14

  S-Adenosylhomocysteine (SAH) provides a ratio-aware way to investigate methyltransferase inhibition alongside radiation-induced neural differentiation. This article translates biochemical context into assay design, controls, and interpretation without claiming that SAH was tested in the underlying neural study.

• Antimycin A4: ATP-Citrate Lyase Inhibitor Workflows

  2026-09-14

  Antimycin A4 supports parallel interrogation of lipid biosynthesis and mitochondrial energy metabolism, provided biochemical and cellular effects are separated experimentally. This practical guide combines dose design, controls, storage guidance, and troubleshooting for more interpretable metabolic assays.

• OM-MSCs, Golgi Stress, and Cerebral IRI

  2026-09-13

  This study identifies a paracrine mechanism by which olfactory mucosa mesenchymal stem cells reduce Golgi apparatus stress after cerebral ischemia/reperfusion injury. Its cellular and rat models connect PEDF secretion with PI3K/Akt/mTOR phosphorylation, improved calcium and oxidative-stress control, and reduced excessive autophagy.

• Phytol Assays: Reliable RXR and Viability Workflows

  2026-09-12

  A scenario-based guide to using Phytol (SKU C5616) in RXR signaling, viability, proliferation, and cytotoxicity workflows. It addresses solvent control, isomer composition, dose selection, orthogonal readouts, storage, and vendor documentation to improve experimental interpretability.

• Bacitracin (B1670): Technical Workflow Guide

  2026-09-11

  Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis disruption. This guide covers preparation, assay controls, storage, and troubleshooting, while defining product-specific limits and excluding diagnostic, clinical, and medical use.

• S. eriocheiris Entry into Drosophila S2 Cells

  2026-09-11

  Wei and colleagues established a Drosophila Schneider 2 cell model to show that Spiroplasma eriocheiris invades insect cells through clathrin-mediated endocytosis and macropinocytosis. The study connects intracellular bacterial accumulation with actin, microtubule, protein kinase C, and myosin II functions, providing a tractable system for dissecting an underexplored crustacean pathogen.

• Actinomycin D: Mapping mRNA Decay in ESCC

  2026-09-10

  Actinomycin D can convert a static RNA measurement into a mechanistic test of transcription and mRNA decay. This article explains how ActD can be positioned within the BCLAF1–YTHDF2–SIX1 axis in esophageal squamous cell carcinoma research, with practical controls, interpretation criteria, and handling guidance.

• β-Elemene: Mechanisms and Research Workflows

  2026-09-10

  β-Elemene, also called Levo-β-elemene in some research contexts, is a plant-derived sesquiterpene used in apoptosis, neuroprotection, inflammation, and metabolic studies. Published 3T3-L1 data show that β-elemene suppresses MDI-induced adipogenesis and restores AMPK-associated signaling under defined cell-culture conditions.

• HyperScribe T7 RNA Synthesis Kit Plus

  2026-09-09

  The HyperScribe T7 High Yield RNA Synthesis Kit Plus is a T7 RNA polymerase in vitro transcription kit for producing research RNA at reported yields of up to 180 μg per 20 μL reaction. Its stated applications include modified RNA workflows and cell-based mRNA studies such as preliminary FLCN rescue experiments.

• Antimycin A4 Workflow for Metabolic Research

  2026-09-09

  Antimycin A4 combines ATP-citrate lyase inhibition with mitochondrial respiratory-chain activity, enabling parallel studies of lipid synthesis and cellular bioenergetics. This workflow shows how to separate those mechanisms experimentally, control DMSO and stability variables, and avoid mistaking mitochondrial toxicity for a lipid-metabolism phenotype.

• Fludarabine: Genotype-Aware Assay Design

  2026-09-08

  Fludarabine is a DNA synthesis inhibitor that connects nucleotide metabolism, replication stress, cell-cycle arrest, and apoptosis. This guide develops a genotype-aware framework for interpreting leukemia and multiple myeloma models rather than treating cytotoxicity as a single endpoint.

• Griseofulvin in Microtubule Mechanism Assays

  2026-09-08

  Griseofulvin combines practical antifungal utility with a tractable microtubule phenotype for fungal growth, mitotic imaging, and aneugen mechanism studies. This workflow connects formulation control and time-resolved phenotyping with the reference study’s flow-cytometric strategy for separating tubulin effects from broader cellular stress.

• Neomycin Sulfate: A Causal Assay Framework

  2026-09-07

  Neomycin sulfate is an aminoglycoside antibiotic that can function as a mechanistic perturbant in nucleic-acid and ion-channel assays. This guide presents a causal assay framework for separating structural binding, catalytic inhibition, channel block, and indirect biological effects.

• Fluorescein TSA Fluorescence System Kit Guide

  2026-09-07

  A scenario-based guide to using the Fluorescein TSA Fluorescence System Kit, SKU K1050, for sensitive endpoint detection in fixed cells and tissues. It explains TSA chemistry, assay compatibility, protocol controls, interpretation limits, storage, and practical vendor-selection criteria for researchers working with viability, proliferation, and cytotoxicity workflows.

709 records 1/48 page Next 12345 下5页 Last page